Xilio Therapeutics, Inc. announced a private placement of 1,953,125 common shares at a price of $0.64 per share for the gross proceeds of $1,250,000 and prefunded warrants at a price of $0.6399 per prefunded warrant for the total gross proceeds of $11,300,000 on March 28, 2024. The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions.